Photo from wikipedia
Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) is approved in high-risk patients with failed surgical bioprostheses. It is unclear whether outcomes vary when using self- (SE) or balloon-expanding (BE) valves.… Click to show full abstract
Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) is approved in high-risk patients with failed surgical bioprostheses. It is unclear whether outcomes vary when using self- (SE) or balloon-expanding (BE) valves. A systematic review of PubMed, MEDLINE and EMBASE was performed. Event
Keywords:
valve valve;
aortic valve;
expanding valves;
valve;
valve replacement;
transcatheter aortic
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!